SecBot SecBot

Expressing support for the designation of June 1, 2026, through June 7, 2026, as "Hidradenitis Suppurativa Awareness Week".

H.Res. 1331 Rep. Debbie Dingell (D-MI-6) In committee
  1. Introduced Jun 2
  2. Committee Jun 2
  3. Agreed to in House Next
Where it stands
In committee, Jun 2, 2026Next: House vote
148d ago Jun 2, 2026: Referred to the House Committee on Energy and Commerce.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
1company, 4 filings
Member trades
1trades in the last 90 days
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

1 company
Companies by sector
Biotech & Pharma 1
Search all 1 companies, their asks and price moves Subscribe

Summary

This resolution expresses support for designating June 1, 2026, through June 7, 2026, as "Hidradenitis Suppurativa Awareness Week." It recognizes Hidradenitis Suppurativa (HS) as a chronic inflammatory skin disease affecting about 3,300,000 people in the United States, causing painful nodules, scarring, and high rates of misdiagnosis and psychological distress. The resolution states that the House of Representatives supports this designation and recognizes the importance of increasing awareness and education about HS, promoting timely diagnosis, supporting biomedical research, accelerating treatment development, and advancing policies to improve access to care and quality of life for people with HS.

Summary of the bill text as introduced in House (Jun 2, 2026), generated by SecBot from the official bill text; the Library of Congress summary is not yet published.

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.